Skip to Main Content

Paper Details

Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors.
Clin Cancer Res
7
2023
/NFB signaling pathway genes, Cancer, GBM, IFN, M1 macrophage, NEAT1, NFB, PD-1, PD-L1, Patients, T cells, TNF, cancer, cell-cycle-related genes, glioblastoma, lncRNA, lncRNA NEAT1, lncRNAs, long noncoding RNA, macrophages, melanoma, microglia, patient, patients, tumor, tumor cells, tumor-infiltrating immune cells, tumor-infiltrating myeloid cells
Author NameAffiliation
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCancer Center and Department of Pathology, Massachusetts General Hospital
Gad GetzHarvard Medical School
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCancer Center and Department of Pathology, Massachusetts General Hospital
Gad GetzHarvard Medical School
Catherine J WuDana-Farber Cancer Institute and Harvard Medical School
Catherine J WuBroad Institute of MIT and Harvard
  • 1 - 8

Datasets